title: Fluoroquinolone prophylaxis: worth the cost?
authors.affiliation: Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
authors.forename: Gabrielle M
authors.initials: GM
authors.lastname: Haeusler
authors.forename: Monica A
authors.initials: MA
authors.lastname: Slavin
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001372:Aza Compounds / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000209:etiology*; D024841:Fluoroquinolones / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D008297:Male; D000077266:Moxifloxacin; D009287:Naphthyridines / Q000627:therapeutic use*; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control*; D011804:Quinolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009287:Naphthyridines; D011804:Quinolines; C055185:tosufloxacin; D000077266:Moxifloxacin